Edit
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Atopic Dermatitis Drugs Market to reach USD 25.33 billion by the end of 2029.

Global Atopic Dermatitis Drugs Market Size study & Forecast, by Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others) by Route of Administration (Topical, Injectable, Oral) and Regional Analysis, 2022-2029

Product Code: HLSDT-78325272
Publish Date: 8-02-2023
Page: 200

Global Atopic Dermatitis Drugs Market is valued at approximately USD 12.71 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.0% over the forecast period 2022-2029. Atopic dermatitis also known as eczema is a chronic, inflammatory skin, and non-contagious condition which affects the skin and leads to red, dry, itchy, and bumpy. The rise in awareness regarding the product availability for the disease, and robust product portfolio, coupled with the increasing expenditure on healthcare services and products are bolstering the market demand worldwide.

The rising incidences of atopic dermatitis is propelling the market demand across the globe. The Acta Derm Venereological Journal reported that in 2020 the doctor diagnosed that the prevalence of atopic dermatitis in adults varied from 17.1% in Europe to 10.2% in Asia; in children, the rates were 22.6% and 0.96%, respectively. Thereby, the high incidences of atopic dermatitis among the population are reinforcing the need for atopic dermatitis drugs to receive timely and suitable treatment, which, in turn, augments the growth of the market. Moreover, increasing product approvals, as well as the growing R&D investments by the key market players present various lucrative opportunities over the forecasting years. However, the high cost of therapeutics and some side effects associated with drugs are hindering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Atopic Dermatitis Drugs Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the growing R&D investment and presence of well-established healthcare infrastructure. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the increase in pro-health initiatives, rise in consumer awareness, as well as strong healthcare reimbursement systems in the market space.

Major market players included in this report are:
Pfizer Inc.
Sanofi
AbbVie Inc.
GALDERMA LABORATORIES, L.P.
Eli Lilly and Company (Dermira)
Regeneron Pharmaceuticals Inc.
LEO Pharma Inc.
Otsuka Pharmaceutical Co., Ltd.
Novartis AG
Incyte Corporation

Recent Developments in the Market:
 In April 2021, AbbVie declared that the company is strengthening its supplemental New Drug Application (sNDA) to review RINVOQ for atopic dermatitis adolescent and adult patients. The Prescription Drug User Fee Act (PDUFA) was extended till quarter 3 of 2021.

Global Atopic Dermatitis Drugs Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Class, Route of Administration, , Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Class:
Corticosteroids
Calcineurin Inhibitors
PDE4 Inhibitors
Biologics
Others
By Route of Administration:
Topical
Injectable
Oral

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Atopic Dermatitis Drugs Market, by Region, 2019-2029 (USD Billion)
1.2.2. Atopic Dermatitis Drugs Market, by Class, 2019-2029 (USD Billion)
1.2.3. Atopic Dermatitis Drugs Market, by Route of Administration, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Atopic Dermatitis Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Atopic Dermatitis Drugs Market Dynamics
3.1. Atopic Dermatitis Drugs Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Robust product portfolio
3.1.1.2. Increasing incidences of atopic dermatitis
3.1.2. Market Challenges
3.1.2.1. High cost of therapeutics
3.1.2.2. Some side-effects associated with drugs
3.1.3. Market Opportunities
3.1.3.1. Increasing product approvals
3.1.3.2. Growing R&D investments by the key market players
Chapter 4. Global Atopic Dermatitis Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Atopic Dermatitis Drugs Market, by Class
6.1. Market Snapshot
6.2. Global Atopic Dermatitis Drugs Market by Class, Performance – Potential Analysis
6.3. Global Atopic Dermatitis Drugs Market Estimates & Forecasts by Class 2019-2029 (USD Billion)
6.4. Atopic Dermatitis Drugs Market, Sub Segment Analysis
6.4.1. Corticosteroids
6.4.2. Calcineurin Inhibitors
6.4.3. PDE4 Inhibitors
6.4.4. Biologics
6.4.5. Others
Chapter 7. Global Atopic Dermatitis Drugs Market, by Route of Administration
7.1. Market Snapshot
7.2. Global Atopic Dermatitis Drugs Market by Route of Administration, Performance – Potential Analysis
7.3. Global Atopic Dermatitis Drugs Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Billion)
7.4. Atopic Dermatitis Drugs Market, Sub Segment Analysis
7.4.1. Topical
7.4.2. Injectable
7.4.3. Oral
Chapter 8. Global Atopic Dermatitis Drugs Market, Regional Analysis
8.1. Atopic Dermatitis Drugs Market, Regional Market Snapshot
8.2. North America Atopic Dermatitis Drugs Market
8.2.1. U.S. Atopic Dermatitis Drugs Market
8.2.1.1. Class breakdown estimates & forecasts, 2019-2029
8.2.1.2. Route of Administration breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Atopic Dermatitis Drugs Market
8.3. Europe Atopic Dermatitis Drugs Market Snapshot
8.3.1. U.K. Atopic Dermatitis Drugs Market
8.3.2. Germany Atopic Dermatitis Drugs Market
8.3.3. France Atopic Dermatitis Drugs Market
8.3.4. Spain Atopic Dermatitis Drugs Market
8.3.5. Italy Atopic Dermatitis Drugs Market
8.3.6. Rest of Europe Atopic Dermatitis Drugs Market
8.4. Asia-Pacific Atopic Dermatitis Drugs Market Snapshot
8.4.1. China Atopic Dermatitis Drugs Market
8.4.2. India Atopic Dermatitis Drugs Market
8.4.3. Japan Atopic Dermatitis Drugs Market
8.4.4. Australia Atopic Dermatitis Drugs Market
8.4.5. South Korea Atopic Dermatitis Drugs Market
8.4.6. Rest of Asia Pacific Atopic Dermatitis Drugs Market
8.5. Latin America Atopic Dermatitis Drugs Market Snapshot
8.5.1. Brazil Atopic Dermatitis Drugs Market
8.5.2. Mexico Atopic Dermatitis Drugs Market
8.5.3. Rest of Latin America Atopic Dermatitis Drugs Market
8.6. Rest of The World Atopic Dermatitis Drugs Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Pfizer Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Sanofi
9.2.3. AbbVie Inc.
9.2.4. GALDERMA LABORATORIES, L.P.
9.2.5. Eli Lilly and Company (Dermira)
9.2.6. Regeneron Pharmaceuticals Inc.
9.2.7. LEO Pharma Inc.
9.2.8. Otsuka Pharmaceutical Co., Ltd.
9.2.9. Novartis AG
9.2.10. Incyte Corporation
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now